Charmacy Pharmaceutical Co., Ltd.
2289.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$593.46M
Close$
Share Statistics
| Market cap | $593.46 Million |
|---|---|
| Enterprise Value | $2.16 Billion |
| Dividend Yield | $0.34 (6.25%) |
| Earnings per Share | $0.43 |
| Beta | -0.96 |
| Outstanding Shares | 108,038,000 |
Return
| Return on Equity | 15.73% |
|---|---|
| Return on Assets | 2.43% |
| Return on Invested Capital | 39.07% |
Valuation & Multiples
| P/E Ratio | 10.88 |
|---|---|
| PEG | 281.01 |
| Price to Sales | 0.07 |
| Price to Book Ratio | 1.1 |
| Enterprise Value to Revenue | 0.24 |
| Enterprise Value to EBIT | 8.35 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.97 |
| Debt to Equity | 3.46 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Charmacy Pharmaceutical Co., Ltd.
827 employees
CEO: Chuanglong Yao Charmacy Pharmaceutical Co., Ltd. serves as a prominent distributor of pharmaceutical products across the People's Republic of China. The company's comprehensive portfolio includes Western medications, traditional Chinese patent medicine...